Speaker Profile

Ph.D., CEO, ARIZ Precision Medicine

Brad Niles received his Ph.D. from UC Davis, with a Designated Emphasis in Biotechnology and advanced training in Business Development. He has 15 years of experience in cancer research, and has published more than a dozen scientific papers. In addition, he has managed product development projects for two biotech startups, and is an inventor on numerous RNA-therapeutic patent applications. At ARIZ he has previously served as COO and VP of Research and Development for over 4 years.

Emerging Therapeutics Showcase:
ARIZ Precision Medicine

ARIZ Precision Medicine is focused on the epigenetic changes that occur in the cancerization of a cell to develop targeted therapeutics. With an innovative approach that utilizes the differences in cancer cells, we can specifically kill cancer cells while sparing healthy cells.

PRDM2: A Druggable Target in Lung Cancer
ARIZ is developing a first in class siRNA therapy for lung cancer, targeting a driver gene that is misregulated in 75% of lung cancers with an siRNA packaged in a drug delivery system that achieves significantly tumor growth inhibition.

 Session Abstract – PMWC 2022 Silicon Valley

Track 7 - June 28 9.30 A.M.-9.45 A.M.,Track 7 - June 29 3.30 P.M.-3.45 P.M.,Track 7 - June 30 1.00 P.M.-1.15 P.M.

The PMWC 2022 Emerging Therapeutics Showcase will provide a 15-minute time slot for selected companies and researchers in the CRISPR, Cell and Gene Therapy fields. Major advancements in safer cell- and gene-level editing technologies are bringing us closer toward cures for life-threatening disorders, from cancer to HIV to Huntington’s disease. Cell therapy, in which cellular material such as T cells capable of fighting cancer cells, is injected into a patient, has been demonstrated safe and effective. The popular new CRISPR tool that has been used to edit the genetic code of nearly any organism will have an enormous impact on human health. More than a dozen clinical trials employing CRISPR on human cells are already underway.

- Emerging Therapeutics/Cell Therapy
- Emerging Therapeutics/CVD
- Emerging Therapeutics/Gene Therapy
- Emerging Therapeutics/Immunotherapy
- Emerging Therapeutics/Radiation Therapy


Add Names/PO on Receipt

Apply to Speak at PMWC Silicon Valley by SEP. 28TH

The PMWC team will reply back to a suitable company/topic with an official request for talk/speaker details.

Contact Us:

Fields marked with an * are required 

Contact Us:

Fields marked with an * are required 

Discover What's Next in Precision Medicine!

Join our community today for the latest news, exclusive interviews, and unique insights from world-renowned speakers and experts

Trouble Registering

Fields marked with an * are required

Stay Tuned For More Information.

Sign up for occasional updates on upcoming conferences, news, and other information. 

Get Updates:

Submit to Speak in the PMWC Showcase

Fields marked with an * are required